Methylergonovine Maleate (Methylergonovine Maleate) (Tablet) 0.2 mg/1

Methylergonovine Maleate 0.2 mg tablets are prescribed to help manage postpartum hemorrhage by supporting uterine contractions. This medication belongs to the ergot alkaloid class and is used after childbirth. It is available as a 0.2 mg oral tablet for short-term use.

Strength

0.2 mg/1

Manufacturer / TM Owner

West-Ward Pharmaceuticals Corp

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Methylergonovine Maleate is primarily used to prevent or treat excessive bleeding following childbirth, a condition known as postpartum hemorrhage. It works by strengthening uterine contractions to reduce blood loss. This medication is typically prescribed for short-term use when bleeding is not controlled by other measures.

Side Effects

After taking Methylergonovine Maleate, users may notice increased uterine firmness and reduced bleeding postpartum. Some individuals report mild nausea or dizziness as common effects. These effects are generally temporary and resolve as the medication leaves the system.

Precautions & Warnings

Methylergonovine Maleate should only be taken as directed by a healthcare provider, typically after delivery. It is not suitable for individuals with certain conditions, such as high blood pressure or heart disease. Always inform your doctor of your full medical history before starting this medication.

Avoid Interactions

This medication may interact with other drugs that affect blood pressure or uterine tone, including some antibiotics and vasoconstrictors. Alcohol and tobacco use may also influence its effects. Always review your current medications with a healthcare professional before combining treatments.

Frequently Asked Questions

It is used to prevent or treat excessive bleeding after childbirth by strengthening uterine contractions.

It is taken orally as directed by a healthcare provider, usually after delivery.

Common side effects may include nausea, dizziness, or headache. Severe effects are rare but require medical attention.

Individuals with high blood pressure, heart disease, or certain allergies should avoid this medication unless approved by a doctor.

It is generally considered safe when used as prescribed after childbirth, but consult your healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.